This might be due to Arg1 secretion and inadequate antigen presentation, leading to reduced CD8+ T cell proliferation, weakened T cell anticancer immunity, enhanced cancer growth, and temporary cancer cell proliferation [121]. Here, CD8A is linked to cancer.